Research Frontiers Incorporated — Form 10-Q Summary
Business Context and Reporting Period
Research Frontiers develops and licenses suspended particle device technology used to control light transmission in glass and plastic applications, including automotive, architectural, aerospace, marine, appliance and display products. The company operates in one business segment and primarily earns licensing and royalty income. This unaudited report covers the three and nine months ended September 30, 2020, compared with the corresponding 2019 periods.
Key Financial Metrics
| Metric | Three Months Ended September 30 | Nine Months Ended September 30 |
|---|---|---|
| Fee income | $165,628 vs. $462,869 | $697,914 vs. $1,182,560 |
| Total expenses | $609,073 vs. $873,724 | $2,391,526 vs. $3,108,187 |
| Operating loss | $(443,445) vs. $(410,855) | $(1,693,612) vs. $(1,925,627) |
| Net loss | $(434,223), or $(0.01) per share | $(1,457,798), or $(0.05) per share |
| Net loss, prior year | $(397,712), or $(0.01) per share | $(2,552,087), or $(0.09) per share |
| Operating margin | Approximately -268% | Approximately -243% |
Cash and cash equivalents were $5.44 million at September 30, 2020, down from $6.59 million at December 31, 2019. Working capital was approximately $5.81 million, total assets were $6.86 million and shareholders’ equity was $5.88 million. The company reported no debt; liabilities consisted primarily of operating lease liabilities totaling $851,672, including current and noncurrent portions. The accumulated deficit was approximately $117.0 million.
Net cash used in operating activities was $1.64 million for the first nine months of 2020, compared with $1.66 million in the prior-year period. Financing provided $486,259, comprising $284,207 from option and warrant exercises and $202,052 from the Paycheck Protection Program. Investing activities provided $1,545. Cash decreased by $1.15 million during the period.
Material Changes Versus the Prior Comparable Period
- Third-quarter fee income decreased $297,241, or approximately 64%, primarily because COVID-19 disrupted licensee manufacturing and reduced automotive and aircraft-related royalties.
- Nine-month fee income decreased $484,646, or approximately 41%, for similar reasons. Lower automotive and aircraft fees were partly offset by higher architectural and display-market income.
- Third-quarter operating expenses declined $193,932, or approximately 29%, due mainly to lower depreciation, patent costs, professional fees and payroll.
- Nine-month operating expenses declined $432,047, or approximately 18%, primarily because 2019 included noncash stock-based compensation, along with lower depreciation, patent and professional costs.
- Research and development expense declined 38% for the nine-month period, to $466,698, reflecting lower payroll, stock-based compensation, materials and allocated costs.
- Nine-month net loss improved by $1.09 million, primarily because 2019 included a $652,025 noncash warrant market adjustment and $356,228 of stock-based compensation, while 2020 included $202,052 of PPP loan forgiveness income.
- Shares outstanding increased to 31,575,786 at September 30, 2020 from 31,254,262 at December 31, 2019, primarily through option and warrant exercises. No equity securities were sold during the 2020 periods.
Guidance, Outlook, Risks and Unusual Items
- Management expects recurring operating losses to continue because licensing revenue has not been sufficient to fund research, development and corporate expenses.
- Management estimates a quarterly cash-flow shortfall of approximately $500,000 to $600,000 over the next 12 months and believes existing working capital could support operations for approximately 27 to 29 months, or until early 2023 based on current expectations.
- Future revenue depends on commercialization of products using the company’s technology by licensees, continued royalty payments, automotive production volumes, adoption in new vehicle and aircraft models, and growth in architectural, marine and other markets.
- COVID-19 caused delays in overseas manufacturing, reduced product sales and royalties, and increased collection risk. The company increased its allowance for uncollectible royalty receivables; the duration and financial impact of the disruption remained uncertain.
- The company received a $202,052 PPP loan and recorded the full amount as other income based on its estimate that the loan would be forgiven. The actual forgiveness remains an item to verify.
- Four license agreements had remaining performance obligations totaling $464,265 at September 30, 2020, expected to be recognized over their remaining initial terms. The filing states that the agreements are expected to renew annually, but renewal is not guaranteed.
- The company may require additional financing if operating cash flow is insufficient. Potential equity financing may be dilutive, and the availability and terms of future funding are uncertain.
- The majority of licensing income is concentrated among a limited number of licensees and is substantially linked to the automotive market, creating customer, industry and production concentration risks.
Important Facts for Investors to Verify
- Whether COVID-19-related manufacturing disruptions and automotive model transitions continue to suppress royalty income.
- Actual collectability of royalty receivables and the adequacy of the allowance for doubtful accounts.
- Final PPP loan forgiveness and any resulting accounting adjustment.
- Whether the projected $500,000–$600,000 quarterly cash shortfall and early-2023 cash runway remain accurate.
- Commercial adoption, production volumes and royalty economics for SPD technology in automotive, aircraft, architectural and other applications.
- Renewal of the four license agreements and realization of the disclosed $464,265 of remaining performance obligations.
- Potential need for additional capital and the dilution or other terms associated with any future financing.